Clinical pharmacology and therapeutics

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease.

Sun H, Frassetto LA, Huang Y, Benet LZ

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease.

Clinical pharmacology and therapeutics

Sun H, Frassetto LA, Huang Y, Benet LZ

A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient.

Clinical pharmacology and therapeutics

Benet LZ

A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient.

Clinical pharmacology and therapeutics

Benet LZ

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.

Clinical pharmacology and therapeutics

Zheng HX, Huang Y, Frassetto LA, Benet LZ

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.

Clinical pharmacology and therapeutics

Zheng HX, Huang Y, Frassetto LA, Benet LZ

Effects of uptake and efflux transporter inhibition on erythromycin breath test results.

Clinical pharmacology and therapeutics

Frassetto LA, Poon S, Tsourounis C, Valera C, Benet LZ

Effects of uptake and efflux transporter inhibition on erythromycin breath test results.

Clinical pharmacology and therapeutics

Frassetto LA, Poon S, Tsourounis C, Valera C, Benet LZ

Review and critique of the Institute of Medicine report "the future of drug safety".

Clinical pharmacology and therapeutics

Benet LZ

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.

Clinical pharmacology and therapeutics

Lau YY, Huang Y, Frassetto L, Benet LZ

Hair Analytical Lab

Clinical pharmacology and therapeutics

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease.

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease.

A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient.

A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient.

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.

Effects of uptake and efflux transporter inhibition on erythromycin breath test results.

Effects of uptake and efflux transporter inhibition on erythromycin breath test results.

Review and critique of the Institute of Medicine report "the future of drug safety".

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.

Pages

Contact Us

Search form

You are here

Clinical pharmacology and therapeutics

Pages

Contact Us